{"id":1460,"date":"2021-12-02T14:28:57","date_gmt":"2021-12-02T13:28:57","guid":{"rendered":"http:\/\/jcet.eu\/new_en\/?p=1460"},"modified":"2021-12-06T13:19:30","modified_gmt":"2021-12-06T12:19:30","slug":"opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies","status":"publish","type":"post","link":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/","title":{"rendered":"OPUS 21 NCN for the development of innovative antithrombotic therapies"},"content":{"rendered":"\n<p><strong>Last week we got to know the results of the OPUS 21 competition announced by the <\/strong><a rel=\"noreferrer noopener\" aria-label=\"National Science Center (opens in a new tab)\" href=\"https:\/\/www.ncn.gov.pl\/en\" target=\"_blank\"><strong>National Science Center<\/strong><\/a><strong> in Cracow. Dr. Patrycja Kaczara is among the scientists who have been awarded funding for the implementation of the research. Dr. Kaczara will implement a project entitled: <\/strong><em><strong>Normalization of energy metabolism as a way to develop innovative antithrombotic therapies<\/strong><\/em><strong>.<\/strong><\/p>\n\n\n\n<p>The aim of the project is to investigate the relationship between the reactivity of blood platelets and their energy metabolism. The development of thrombosis is accompanied by increased platelet reactivity, caused, among others, by diseases such as diabetes or atherosclerosis, both accompanied by disturbances of metabolic processes. The hypothesis of the project assumes that the pharmacological normalization of metabolic processes in platelets can lead to an improvement of the effectiveness of commonly used antiplatelet drugs. The results of the project can be used to formulate dietary guidelines to help slow the development of thrombosis and to demonstrate the potential of biochemical pathways to develop new antiplatelet therapies to prevent or reduce the serious and life-threatening effects of thrombosis. <\/p>\n\n\n\n<figure class=\"wp-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"810\" height=\"450\" src=\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png\" alt=\"\" class=\"wp-image-1461\" srcset=\"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png 810w, https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK-300x167.png 300w, https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK-768x427.png 768w\" sizes=\"auto, (max-width: 810px) 100vw, 810px\" \/><\/figure>\n\n\n\n<!--more-->\n\n\n\n<ul class=\"wp-block-list\"><li>Budget: PLN 2 052 717<\/li><li>Implementation period: 36 months<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Last week we got to know the results of the OPUS 21 competition announced by the National Science Center in Cracow. Dr. Patrycja Kaczara is among the scientists who have been awarded funding for the implementation of the research. Dr.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1460","post","type-post","status-publish","format-standard","hentry","category-varia"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>OPUS 21 NCN for the development of innovative antithrombotic therapies &#187; JCET<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OPUS 21 NCN for the development of innovative antithrombotic therapies &#187; JCET\" \/>\n<meta property=\"og:description\" content=\"Last week we got to know the results of the OPUS 21 competition announced by the National Science Center in Cracow. Dr. Patrycja Kaczara is among the scientists who have been awarded funding for the implementation of the research. Dr.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"JCET\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/jcet.eu\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-02T13:28:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-06T12:19:30+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png\" \/>\n<meta name=\"author\" content=\"Agnieszka Gudek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Agnieszka Gudek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/\"},\"author\":{\"name\":\"Agnieszka Gudek\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9\"},\"headline\":\"OPUS 21 NCN for the development of innovative antithrombotic therapies\",\"datePublished\":\"2021-12-02T13:28:57+00:00\",\"dateModified\":\"2021-12-06T12:19:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/\"},\"wordCount\":189,\"publisher\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#organization\"},\"image\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png\",\"articleSection\":[\"Varia\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/\",\"url\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/\",\"name\":\"OPUS 21 NCN for the development of innovative antithrombotic therapies &#187; JCET\",\"isPartOf\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png\",\"datePublished\":\"2021-12-02T13:28:57+00:00\",\"dateModified\":\"2021-12-06T12:19:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage\",\"url\":\"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png\",\"contentUrl\":\"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png\",\"width\":810,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jcet.eu\/new_en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OPUS 21 NCN for the development of innovative antithrombotic therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#website\",\"url\":\"https:\/\/jcet.eu\/new_en\/\",\"name\":\"JCET\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jcet.eu\/new_en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#organization\",\"name\":\"Jagiellonian Centre for Experimental Therapeutics (JCET)\",\"url\":\"https:\/\/jcet.eu\/new_en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png\",\"contentUrl\":\"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png\",\"width\":715,\"height\":401,\"caption\":\"Jagiellonian Centre for Experimental Therapeutics (JCET)\"},\"image\":{\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/jcet.eu\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9\",\"name\":\"Agnieszka Gudek\",\"sameAs\":[\"http:\/\/admin\"],\"url\":\"https:\/\/jcet.eu\/new_en\/author\/agag\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OPUS 21 NCN for the development of innovative antithrombotic therapies &#187; JCET","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/","og_locale":"en_GB","og_type":"article","og_title":"OPUS 21 NCN for the development of innovative antithrombotic therapies &#187; JCET","og_description":"Last week we got to know the results of the OPUS 21 competition announced by the National Science Center in Cracow. Dr. Patrycja Kaczara is among the scientists who have been awarded funding for the implementation of the research. Dr.","og_url":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/","og_site_name":"JCET","article_publisher":"https:\/\/www.facebook.com\/jcet.eu\/","article_published_time":"2021-12-02T13:28:57+00:00","article_modified_time":"2021-12-06T12:19:30+00:00","og_image":[{"url":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png","type":"","width":"","height":""}],"author":"Agnieszka Gudek","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Agnieszka Gudek","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#article","isPartOf":{"@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/"},"author":{"name":"Agnieszka Gudek","@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9"},"headline":"OPUS 21 NCN for the development of innovative antithrombotic therapies","datePublished":"2021-12-02T13:28:57+00:00","dateModified":"2021-12-06T12:19:30+00:00","mainEntityOfPage":{"@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/"},"wordCount":189,"publisher":{"@id":"https:\/\/jcet.eu\/new_en\/#organization"},"image":{"@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png","articleSection":["Varia"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/","url":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/","name":"OPUS 21 NCN for the development of innovative antithrombotic therapies &#187; JCET","isPartOf":{"@id":"https:\/\/jcet.eu\/new_en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage"},"image":{"@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png","datePublished":"2021-12-02T13:28:57+00:00","dateModified":"2021-12-06T12:19:30+00:00","breadcrumb":{"@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#primaryimage","url":"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png","contentUrl":"https:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2021\/12\/PK.png","width":810,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/jcet.eu\/new_en\/2021\/12\/02\/opus-21-ncn-for-the-development-of-innovative-antithrombotic-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jcet.eu\/new_en\/"},{"@type":"ListItem","position":2,"name":"OPUS 21 NCN for the development of innovative antithrombotic therapies"}]},{"@type":"WebSite","@id":"https:\/\/jcet.eu\/new_en\/#website","url":"https:\/\/jcet.eu\/new_en\/","name":"JCET","description":"","publisher":{"@id":"https:\/\/jcet.eu\/new_en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jcet.eu\/new_en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/jcet.eu\/new_en\/#organization","name":"Jagiellonian Centre for Experimental Therapeutics (JCET)","url":"https:\/\/jcet.eu\/new_en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/","url":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png","contentUrl":"http:\/\/jcet.eu\/new_en\/wp-content\/uploads\/2022\/06\/JCET-logo.png","width":715,"height":401,"caption":"Jagiellonian Centre for Experimental Therapeutics (JCET)"},"image":{"@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/jcet.eu\/"]},{"@type":"Person","@id":"https:\/\/jcet.eu\/new_en\/#\/schema\/person\/aa0014c9ab5728df0c0977a4c5985ed9","name":"Agnieszka Gudek","sameAs":["http:\/\/admin"],"url":"https:\/\/jcet.eu\/new_en\/author\/agag\/"}]}},"_links":{"self":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts\/1460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/comments?post=1460"}],"version-history":[{"count":3,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts\/1460\/revisions"}],"predecessor-version":[{"id":1466,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/posts\/1460\/revisions\/1466"}],"wp:attachment":[{"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/media?parent=1460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/categories?post=1460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jcet.eu\/new_en\/wp-json\/wp\/v2\/tags?post=1460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}